QuickCareAI is revolutionizing healthcare accessibility with AI-powered clinical trial matching, comprehensive health management, and 24/7 medical support serving 25,000+ users
Healthcare AI is the fastest-growing sector with unprecedented demand for accessible, intelligent healthcare solutions
Expected market size by 2028, growing at 37.5% CAGR. QuickCareAI is positioned to capture significant market share in the consumer healthcare AI segment.
Clinical trials market size with massive inefficiencies in patient recruitment. Our AI matching reduces recruitment time by 85%.
US healthcare spending annually. QuickCareAI saves users $5,000+ per year through early intervention and preventive care.
Americans living in healthcare shortage areas. Our 24/7 AI healthcare team provides instant access to medical expertise anywhere.
Subscription-based SaaS model with multiple revenue streams and strong unit economics
Strong fundamentals with consistent month-over-month growth across all key metrics
Multiple moats protecting our market position and enabling long-term value creation
Built on Claude AI with proprietary healthcare training data, delivering superior accuracy and user experience that competitors cannot replicate.
Exclusive access to 400,000+ active trials with proprietary matching algorithms that achieve 95%+ accuracy in patient-trial compatibility.
Revolutionary AI-powered image analysis rivaling specialist diagnostics, providing instant analysis of ECGs, X-rays, lab results, and more.
40+ integrated health features with 9 specialized AI doctors, creating high switching costs and strong user retention.
Growing user data improves AI accuracy for all users, while clinical trial partnerships expand based on successful patient matches.
HIPAA compliant, ISO 27001 certified infrastructure creating significant barriers to entry for new competitors.
Conservative projections based on current growth trends and market expansion opportunities
We're raising a Series A to accelerate growth, expand internationally, and become the global leader in AI-powered healthcare accessibility
All investor communications are confidential and subject to NDA • Accredited investors only